Stigma and the acceptability of depression treatments among african americans and whites.

Boston University Medical Center, Geriatrics Section, Boston, MA 02118-2393, USA.
Journal of General Internal Medicine (Impact Factor: 3.42). 09/2007; 22(9):1292-7. DOI: 10.1007/s11606-007-0276-3
Source: PubMed

ABSTRACT Stigma is associated with depression treatment, however, whether stigma differs between depression treatment modalities is not known, nor have racial differences in depression treatment stigma been fully explored.
To measure stigma for four depression treatments and estimate its association with treatment acceptability for African Americans and whites.
Cross-sectional, anonymous mailed survey.
Four hundred and ninety African-American and white primary care patients.
The acceptability of four depression treatments (prescription medication, mental health counseling, herbal remedy, and spiritual counseling) was assessed using a vignette. Treatment-specific stigma was evaluated by asking whether participants would: (1) feel ashamed; (2) feel comfortable telling friends and family; (3) feel okay if people in their community knew; and (4) not want people at work to know about each depression treatment. Sociodemographics, depression history, and current depressive symptoms were measured.
Treatment-specific stigma was lower for herbal remedy than prescription medication or mental health counseling (p < .01). Whites had higher stigma than African Americans for all treatment modalities. In adjusted analyses, stigma relating to self [AOR 0.43 (0.20-0.95)] and friends and family [AOR 0.42 (0.21-0.88)] was associated with lower acceptability of mental health counseling. Stigma did not account for the lower acceptability of prescription medication among African Americans.
Treatment associated stigma significantly affects the acceptability of mental health counseling but not prescription medication. Efforts to improve depression treatment utilization might benefit from addressing concerns about stigma of mental health counseling.

  • The Lancet Psychiatry 04/2015; DOI:10.1016/S2215-0366(15)00002-4
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Treatment of psychiatric patients with psychosomatic or somatic symptoms needs special at-tention. Methods: We examined correlates, change and recovery from depression among psychiatric pa-tients (n = 150) during the assessment of their work ability. Patients were referred to an open psychiatric ward during 8/2004-9/2005. Psychiatric diseases were diagnosed with the ICD-10 by the psychiatrist, but also the Structured Clinical Interview for DSM-IV (SCID I and II) was conducted. The patients replied to questionnaires after admission and before dis-charge including questions on life changes, somatic health, psychosocial and health-related factors as well as psychometric scales for depression (BDI), life sat-isfaction (LS) and general psychopathology (SCL). RESULTS. At baseline, 75% of the patients reported clinically significant depression (BDI > 15) and a quarter of them experienced their depression as se-vere (BDI ≥ 30). Whereas, according to ICD-10 guide-lines, 91% of the patients suffered from depressive disorder and 66% of them from major depression. The average duration of inpatient evaluation was 24 (SD 9, 4) days. Baseline poor general health, life dis-satisfaction, psychosomatic symptoms, bodily pains as well as poor financial situation and adverse life events predicted prevailing depression at discharge. Clinical symptoms improved significantly, especially among younger patients, recovery could not be reached by the time of discharge. Conclusions: Psychiatric pa-tients with somatic complaints tended to under-rate their depression. To enhance their recovery, long-term and individually planned out-patient treatment and surveillance are needed.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent reports reveal that more university students arrive on campus with pre-existing psychological disabilities and concomitant psychotropic medication use. With all new medications the importance of pharmacotherapy services becomes more critical, especially in health-disparate, underserved populations that may additionally have varying perceptions of the role and benefit of medications. This was an exploratory study to improve understanding of mental health needs and help-seeking behaviors among college students at a Historically Black College and University (HBCU), and to identify considerations for cultural adaptations to community-based psychopharmacotherapy services. For this study spirituality and attitudes to mental health, medications and counseling were explored. Data was collected by web-based surveys, student focus groups, depression/suicide vulnerability screenings, and overview of existing campus services. Results suggest higher levels of depression and religiosity, difference in views of medication helpfulness with religiosity level, no difference in views on counseling helpfulness or use of academic versus non-academic resources in times of distress. Further study is warranted. Considerations for service development include destigmatization and trust-building strategies, screening and referral settings with access or referral to spiritual care, collaborative practice agreements (CPA), medication therapy management (MTM), health center surveys, peer support groups, and medication counseling for comorbid conditions (e.g. diabetes, HIV/AIDS). Greater understanding of attitudes and resources turned to in times of distress can help direct resources and train personnel who identify student need, intervene, and extend access to comprehensive mental health service resources in community. Key words: cultural adaptation, spirituality, psychiatry, mental health services, MTM


Available from